Cohance Lifesciences Quarterly Results for Trading Insights
COHANCE • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹66 Cr
QSept 2025
Cohance Lifesciences Quarterly Results Key Highlights
- Revenue of ₹571 Cr in Sept 2025 (-33.1% vs Mar 2025, -7.9% vs Sept 2024)
- Net Profit of ₹66 Cr in Sept 2025 (-43.6% vs Mar 2025, -52.2% vs Sept 2024)
- EBITDA of ₹137 Cr in Sept 2025 (-39.4% vs Mar 2025)
- Operating Margin of 22.0% in Sept 2025 (-3.0pp vs Mar 2025)
- Earnings Per Share of ₹1.94 in Sept 2025 (-38.6% vs Mar 2025)
Cohance Lifesciences Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 571 | 853 | 564 | 551 | 620 | -33.1% | -7.9% |
| Net Profit (₹ Cr) | 66 | 117 | 46 | 29 | 138 | - | - |
| EBITDA (₹ Cr) | 137 | 226 | 118 | 97 | 222 | - | - |
| EPS (₹) | 1.94 | 3.16 | 1.28 | 0.96 | 3.63 | - | - |
| Operating Margin (%) | 22.0% | 25.0% | 19.0% | 17.0% | 34.0% | - | - |
Cohance Lifesciences Share Price Trend Around Quarterly Results
Visualize Cohance Lifesciences's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for Cohance Lifesciences
Additional stock information and data for COHANCE
Revenue Trend (₹ Cr)
Dec 2025
551
Jun 2025
564
Mar 2025
853
Sept 2025
571
Net Profit Trend (₹ Cr)
Dec 2025
29
Jun 2025
46
Mar 2025
117
Sept 2025
66
Operating Margin Trend (%)
Dec 2025
17.0%
Jun 2025
19.0%
Mar 2025
25.0%
Sept 2025
22.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Cohance Lifesciences quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹406,351.37 Cr | 1693.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 130.3 |
|
Divis Laboratories
Sept 2025 |
₹155,471.67 Cr | 5856.5 | 2,860 | 689 | +7.1% | - | 24.1% | 225.5 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹134,944.97 Cr | 3987.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.3 |
|
Lupin
Sept 2025 |
₹103,954.48 Cr | 2274.5 | 6,921 | 1,485 | +23.2% | - | 21.5% | 70.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹101,601.09 Cr | 1217.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 75.2 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores